You
are here:Home
/
Agenda
/
Striking the Balance between Pharmaceutical Innovation and Drug Accessibility in the Developing Countries: the South African GSK Case and the Indian Novartis Case
Striking the Balance between Pharmaceutical Innovation and Drug Accessibility in the Developing Countries: the South African GSK Case and the Indian Novartis Case